Yonhap Infomax NewsHugel Inc. announced plans to reach 900 billion won ($675 million) in annual revenue by 2028, targeting 30% of sales from the US market, with a focus on expanding its botulinum toxin business and maintaining a 50% EBITDA margin.
#YonhapInfomax #HugelInc #AnnualRevenue #USMarket #BotulinumToxin #EBITDAMargin #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=100165
#YonhapInfomax #HugelInc #AnnualRevenue #USMarket #BotulinumToxin #EBITDAMargin #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=100165
Hugel Targets 900 Billion Won in Annual Revenue by 2028—Aims for 30% of Sales from US Market
Hugel Inc. announced plans to reach 900 billion won ($675 million) in annual revenue by 2028, targeting 30% of sales from the US market, with a focus on expanding its botulinum toxin business and maintaining a 50% EBITDA margin.